While genes and loci in proximity to ChREBP binding sites were enriched for variants that associated with hypertriglyceridemia, of the thousands of hepatic ChREBP binding sites, only about 2% of such sites contributed to the enrichment. This evidence concerns the gene MLXIPL and hypertriglyceridemia.